Healthcare -
Biotechnology - NASDAQ - US
$ 465.0
6.07 %
$ 120 B
Market Cap
-244.74
P/E
VRTX - SHORT-TERM DEBT
Short-term Debt VRTX - Vertex Pharmaceuticals Incorporated
83.7 M
LAST VALUE
2.16%
2 YEAR CAGR
40.87%
5 YEAR CAGR
17.36%
10 YEAR CAGR